Ninna A. P.
- Country
- Denmark
- Department
- Oncology Department
Research Overview
- Randomized Phase II/III Study of Cabozantinib Maintenance Versus Best Supportive Care in Osteosarcoma Patients After First‑Line Chemotherapy (FOSTER‑CabOS)
- (Peak) A Phase 3 Randomized, Open-label, Multicenter Clinical Study of CGT9486+Sunitinib vs Sunitinib in Subjects with Locally Advanced, Unresectable, or Metastatic Gastrointestinal Stromal Tumors
- PERELI - A phase 2, open label study of PEmigatinib and REtifanlimab in advanced dedifferentiated Liposarcoma
Data & Insights
Has run more than one trial at 100 of 238 partner sites.
Specializations
Sarcoma Research
This investigator specializes in the treatment of retroperitoneal sarcomas, with particular expertise in managing high-risk dedifferentiated liposarcoma (DDLPS) and leiomyosarcoma (LMS).
- Retroperitoneal Space Tumors
- Infra-peritoneal Pelvic Malignancies
- Soft Tissue Sarcomas
The investigator focuses on developing treatment strategies for primary sarcomas in complex anatomical locations.
Surgical Oncology
The investigator explores innovative approaches in surgical oncology, particularly investigating the role of curative-intent surgery in treating aggressive soft tissue malignancies.
- Surgical Treatment Planning
- Curative Surgical Interventions
- Complex Tumor Resection
Their work encompasses advanced surgical techniques for managing high-risk sarcomas.
Multimodal Therapy
This specialist investigates combined treatment approaches, specifically studying the integration of preoperative chemotherapy with surgical interventions.
- Neoadjuvant Treatment
- Treatment Sequencing
- Disease-Free Survival Assessment
The research explores optimal timing and combination of different therapeutic modalities.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.